| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |